Completed PHASE4 INTERVENTIONAL 2-arm NCT01082627

Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel Obstruction

Prospective, Multi-centers, Investigator Sponsored, Randomized Controlled Trial Towards Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel Obstruction

Sponsor: Nanjing PLA General Hospital

Conditions Small Bowel Obstruction

Interventions Somatostatin common daily practice

Updated 5 times since 2017 Last updated: Aug 2, 2011 Started: Jun 30, 2009 Primary completion: Nov 30, 2010 Completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01082627, this PHASE4 trial focuses on Small Bowel Obstruction and remains completed. Sponsored by Nanjing PLA General Hospital, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nanjing PLA General Hospital

Data source: Nanjing PLA General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China